There are lots of different ways to look at the reach of an article. You can look at citations, Altmetric Attention Scores, awards, and more. One way to consider the influence of an article is just by looking at how many people chose to read it. To that end, we’ve compiled lists of the five […]
There are lots of different ways to look at the reach of an article. You can look at citations, Altmetric Attention Scores, awards, and more. One way to consider the influence of an article is just by looking at how many people chose to read it. To that end, we’ve compiled lists of the five most-read chemistry articles that appeared in each ACS Publications journal in November 2019, including research, reviews, perspectives, and editorial pieces. These lists were not chosen by the journal’s editors and should not be taken as a “best of” list, but as another perspective on where the chemistry community allocated their attention.
Get free monthly updates on the most-read research in your field.
Read more of November’s most-read articles.
***
Doxorubicin–Metal Coordinated Micellar Nanoparticles for Intracellular Codelivery and Chemo/Chemodynamic Therapy in Vitro
DOI: 10.1021/acsabm.9b00879
Cucurbit[7]uril-Anchored Porphyrin-Based Multifunctional Molecular Platform for Photodynamic Antimicrobial and Cancer Therapy
DOI: 10.1021/acsabm.9b00763
Stabilization of Fibronectin by Random Copolymer Brushes Inhibits Macrophage Activation
DOI: 10.1021/acsabm.9b00815
NIR-Triggered Theranostic Bi2S3 Light Transducer for On-Demand NO Release and Synergistic Gas/Photothermal Combination Therapy of Tumors
DOI: 10.1021/acsabm.9b00522
Engineering Human-Scale Artificial Bone Grafts for Treating Critical-Size Bone Defects
DOI: 10.1021/acsabm.9b00756
[/expand]
***
Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors
DOI: 10.1021/acsmedchemlett.9b00381
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors
DOI: 10.1021/acsmedchemlett.9b00141
Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis
DOI: 10.1021/acsmedchemlett.9b00377
Escaping from Flatland: [2 + 2] Photocycloaddition; Conformationally Constrained sp3-rich Scaffolds for Lead Generation
DOI: 10.1021/acsmedchemlett.9b00409
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
DOI: 10.1021/acsmedchemlett.9b00344
[/expand]
***
Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors
DOI: 10.1021/acsmedchemlett.9b00381
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors
DOI: 10.1021/acsmedchemlett.9b00141
Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis
DOI: 10.1021/acsmedchemlett.9b00377
Escaping from Flatland: [2 + 2] Photocycloaddition; Conformationally Constrained sp3-rich Scaffolds for Lead Generation
DOI: 10.1021/acsmedchemlett.9b00409
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
DOI: 10.1021/acsmedchemlett.9b00344
[/expand]